122 related articles for article (PubMed ID: 12515179)
21. Evaluation of multiple antibodies to Epstein-Barr virus as markers for detecting patients with nasopharyngeal carcinoma.
Liu MY; Chang YL; Ma J; Yang HL; Hsu MM; Chen CJ; Chen JY; Yang CS
J Med Virol; 1997 Jul; 52(3):262-9. PubMed ID: 9210034
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
[TBL] [Abstract][Full Text] [Related]
23. [Improve on serological diagnosis method of nasopharyngeal carcinoma].
Zhan SB; Zhong JM; Mai ZP; Ye SQ; Zhou L; Zeng Y; Liao J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):65-7. PubMed ID: 19799023
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma.
Tang JW; Rohwäder E; Chu IM; Tsang RK; Steinhagen K; Yeung AC; To KF; Chan PK
J Clin Virol; 2007 Dec; 40(4):284-8. PubMed ID: 17977062
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
Tsang RK; Vlantis AC; Ho RW; Tam JS; To KF; van Hasselt CA
Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902
[TBL] [Abstract][Full Text] [Related]
26. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
27. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of IgA/VCA, IgA/EA, IgG/EA in immunoenzyme methods and ZEBRA ELISA in early diagnosis of nasopharyngeal carcinoma.].
Zhang XM; Zhong JM; Tang MZ; Zhang XG; Liao J; Zheng YM; Deng H; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Sep; 20(3):263-5. PubMed ID: 17086289
[TBL] [Abstract][Full Text] [Related]
29. [Screening of dominant epitopes of antigens related to antibodies in the sera of patients with nasopharyngeal carcinoma].
Zhang Y; Xiao XB; Zhang CQ; Li JL; Sun Y; Ye YZ; Feng KT
Ai Zheng; 2004 Sep; 23(9):999-1004. PubMed ID: 15363190
[TBL] [Abstract][Full Text] [Related]
30. Serological diagnosis of nasopharyngeal carcinoma by enzyme linked immunosorbent assay: optimization, standardization and diagnostic criteria.
Ng MH; Chen HL; Luo RX; Chan KH; Woo PC; Sham JS; Huang J; Seto WH; Smith P; Griffin BE
Chin Med J (Engl); 1998 Jun; 111(6):531-6. PubMed ID: 11245074
[TBL] [Abstract][Full Text] [Related]
31. Detection and analysis of anti-latent membrane protein 2A antibodies in the sera of patients with Epstein-Barr virus associated malignancies.
Chen Y; Yao K; Sun H; Qing J; Peng GY
Chin Med J (Engl); 2005 May; 118(9):725-30. PubMed ID: 15899133
[TBL] [Abstract][Full Text] [Related]
32. Detection of Epstein-Barr virus DNA in plasma/serum: a useful serological indicator for diagnosis of nasopharyngeal carcinoma.
Mai S; Zong Y; Zhang M; Zhong B; Lin S
Chin Med J (Engl); 2002 Dec; 115(12):1895-7. PubMed ID: 12622949
[TBL] [Abstract][Full Text] [Related]
33. Elevation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma.
Yoshizaki T; Miwa H; Takeshita H; Sato H; Furukawa M
J Cancer Res Clin Oncol; 2000 Feb; 126(2):69-73. PubMed ID: 10664244
[TBL] [Abstract][Full Text] [Related]
34. [IgG and IgA antibodies to the Epstein-Barr virus and nasopharyngeal carcinoma].
Vera Sempere FJ
Med Clin (Barc); 1992 May; 98(19):758-9. PubMed ID: 1318986
[No Abstract] [Full Text] [Related]
35. [Significance of detection of serum sialic acid and Epstein-Barr virus VCA-IgA in diagnosis and monitoring radiotherapy effectiveness in nasopharyngeal carcinoma patients].
Jiang LN; Dai LC; He JF; Chen YW; Ma ZH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):30-2. PubMed ID: 16816858
[TBL] [Abstract][Full Text] [Related]
36. Antibody response to Epstein-Barr virus Rta protein in patients with nasopharyngeal carcinoma: a new serologic parameter for diagnosis.
Feng P; Chan SH; Soo MY; Liu D; Guan M; Ren EC; Hu H
Cancer; 2001 Oct; 92(7):1872-80. PubMed ID: 11745260
[TBL] [Abstract][Full Text] [Related]
37. [Detection of early NPC from VCA/IgA antibody positive individuals with anticomplement immunoenzymatic method].
Zeng Y; Shen SJ; Deng H; Ma JL; Zhang Q; Zhu JS; Cheng JR
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Aug; 4(4):254-5. PubMed ID: 6295651
[No Abstract] [Full Text] [Related]
38. Combination of native and recombinant cytomegalovirus antigens in a new ELISA for detection of CMV-specific antibodies.
Busse C; Strubel A; Schnitzler P
J Clin Virol; 2008 Oct; 43(2):137-41. PubMed ID: 18621576
[TBL] [Abstract][Full Text] [Related]
39. Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome.
Beqaj SH; Lerner AM; Fitzgerald JT
J Clin Pathol; 2008 May; 61(5):623-6. PubMed ID: 18037660
[TBL] [Abstract][Full Text] [Related]
40. [Purification and application of viral capsid antigen of Epstein-Barr virus].
Zhou W; Gu S
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):252-5. PubMed ID: 15617341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
